Vasodilatory and electrophysiological actions of 8-iso-prostaglandin E2 in porcine coronary artery

Journal of Pharmacology and Experimental Therapeutics

Volumn 305, Issue 3, 2003, Pages 1054-1060

  Zhang, Y ^a   Tazzeo, T ^a   Hirota, S ^a   Janssen, L J ^a,b  

^a ST JOSEPH S HOSPITAL   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 4 AMINOPYRIDINE; 8 ISOPROSTAGLANDIN E1; 8 ISOPROSTAGLANDIN E2; 8 ISOPROSTAGLANDIN F1 ALPHA; 8 ISOPROSTAGLANDIN F1 BETA; 8 ISOPROSTAGLANDIN F2 ALPHA; 8 ISOPROSTAGLANDIN F2 BETA; BRADYKININ; CHARYBDOTOXIN; ISOPROSTANE; POTASSIUM CHLORIDE; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFICACY; DRUG POTENCY; ELECTROPHYSIOLOGY; ENDOTHELIUM; HYPERPOLARIZATION; NONHUMAN; PATCH CLAMP; POTASSIUM CONDUCTANCE; POTASSIUM CURRENT; PRIORITY JOURNAL; SWINE; VASODILATATION;

ANIMALS; AORTA; CORONARY VESSELS; DINOPROSTONE; ELECTROPHYSIOLOGY; ENDOTHELIUM, VASCULAR; EVOKED POTENTIALS; ISOPROSTANES; POTASSIUM; PROSTAGLANDINS F; SWINE; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 0038814239     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.049353     Document Type: Article

References (39)

1. Adeagbo AS (1997) Endothelium-derived hyperpolarizing factor: characterization as a cytochrome P450 1A-linked metabolite of arachidonic acid in perfused rat mesenteric prearteriolar bed. Am J Hypertens 10:763-771.
2. Balwierczak JL, Krulan CM, Kim HS, DelGrande D, Weiss GB, and Hu S (1995) Evidence that BKCa channel activation contributes to K+ channel opener induced relaxation of the porcine coronary artery. Naunyn Schmiedebergs Arch Pharmacol 352:213-221.
3. Barlow RS and White RE (1998) Hydrogen peroxide relaxes porcine coronary arteries by stimulating BKCa channel activity. Am J Physiol 275:H1283-H1289.
4. Bauersachs J, Hecker M, and Busse R (1994) Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. Br J Pharmacol 113:1548-1553.
5. Busse R, Edwards G, Feletou M, Fleming I, Vanhoutte P, and Weston A (2002) EDHF: bringing the concepts together. Trends Pharmacol Sci 23:374-380.
6. Chataigneau T, Feletou M, Thollon C, Villeneuve N, Vilaine JP, Duhault J, and Vanhoutte PM (1998) Cannabinoid CB1 receptor and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries. Br J Pharmacol 123:968-974.
7. Christman BW, Robbins JM, Gaine S, Loyd JD, Rubin LJ, Price P, and Barst BJ (1998) Oxidant stress correlates with impairment of tissue oxygenation in patients with pulmonary hypertension. Am J Respir Crit Care Med 157:A593.
8. Cowan CL and Cohen RA (1991) Two mechanisms mediate relaxation by bradykinin of pig coronary artery: NO-dependent and -independent responses. Am J Physiol 261:H830-H835.
9. Cowan CL and Cohen RA (1992) Different mechanisms of relaxation of pig coronary artery to bradykinin and cromakalim are distinguished by potassium channel blockers. J Pharmacol Exp Ther 260:248-253.
10. Fleming I, Michaelis UR, Bredenkotter D, Fisslthaler B, Dehghani F, Brandes RP, and Busse R (2001) Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res 88:44-51.
11. Fulton D, McGiff JC, Wolin MS, Kaminski P, and Quilley J (1997) Evidence against a cytochrome P450-derived reactive oxygen species as the mediator of the nitric oxide-independent vasodilator effect of bradykinin in the perfused heart of the rat. J Pharmacol Exp Ther 280:702-709.
12. Grainger J and Boachie-Ansah G (2001) Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels. Br J Pharmacol 134:1003-1012.
13. Hamill OP, Marty A, Neher E, Sakmann B, and Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391:85-100.
14. Harris D, McCulloch AI, Kendall DA, and Randall MD (2002) Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed. J Physiol 539:893-902.
15. Hayabuchi Y, Nakaya Y, Matsuoka S, and Kuroda Y (1998a) Endothelium-derived hyperpolarizing factor activates Ca2+-activated K+ channels in porcine coronary artery smooth muscle cells. J Cardiovasc Pharmacol 32:642-649.
16. Hayabuchi Y, Nakaya Y, Matsuoka S, and Kuroda Y (1998b) Hydrogen peroxide-induced vascular relaxation in porcine coronary arteries is mediated by Ca2+-activated K+ channels. Heart Vessels 13:9-17.
17. Hecker M, Bara AT, Bauersachs J, and Busse R (1994) Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J Physiol 481 (Pt 2):407-414.
18. Janssen LJ (2001) Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 280:L1067-L1082.
19. Janssen LJ (2002) Are endothelium-derived hyperpolarizing and contracting factors isoprostanes? Trends Pharmacol Sci 23:59-62.
20. Janssen LJ, Premji M, Netherton S, Catalli A, Cox G, Keshavjee S, and Crankshaw DJ (2000) Excitatory and inhibitory actions of isoprostanes in human and canine airway smooth muscle. J Pharmacol Exp Ther 295:506-511.
21. Janssen LJ, Premji M, Netherton S, Coruzzi J, Lu-Chao H, and Cox PG (2001) Vasoconstrictor actions of isoprostanes via tyrosine kinase and Rho kinase in human and canine pulmonary vascular smooth muscles. Br J Pharmacol 132:127-134.
22. Janssen LJ and Tazzeo T (2002) Involvement of TP and EP3 receptors in vasoconstrictor responses to isoprostanes in pulmonary vasculature. J Pharmacol Exp Ther 301:1060-1066.
23. Jourdan KB, Evans TW, Curzen NP, and Mitchell JA (1997) Evidence for a dilator function of 8-iso-prostaglandin F2 alpha in rat pulmonary artery. Br J Pharmacol 120:1280-1285.
24. Kromer BM and Tippins JR (1999) The vasoconstrictor effect of 8-epi prostaglandin F2alpha in the hypoxic rat heart. Br J Pharmacol 126:1171-1174.
25. Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, Kanaide H, and Takeshita A (2000) Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Investig 106:1521-1530.
26. McGuire JJ, Ding H, and Triggle CR (2001) Endothelium-derived relaxing factors: a focus on endothelium-derived hyperpolarizing factor(s). Can J Physiol Pharmacol 79:443-470.
27. Mobert J and Becker BF (1998) Cyclooxygenase inhibition aggravates ischemia-reperfusion injury in the perfused guinea pig heart: involvement of isoprostanes. J Am Coll Cardiol 31:1687-1694.
28. Mobert J, Becker BF, Zahler S, and Gerlach E (1997) Hemodynamic effects of isoprostanes (8-iso-prostaglandin F2alpha and E2) in isolated guinea pig hearts. J Cardiovasc Pharmacol 29:789-794.
29. Oguogho A, Mehrabi M, and Sinzinger H (1999) Increased plasma, serum and urinary 8-epi-prostaglandin F2 alpha in heterozygous hypercholesterolemia. Wien Klin Wochenschr 111:113-118.
30. Pomposiello S, Rhaleb NE, Alva M, and Carretero OA (1999) Reactive oxygen species: role in the relaxation induced by bradykinin or arachidonic acid via EDHF in isolated porcine coronary arteries. J Cardiovasc Pharmacol 34:567-574.
31. Pratico D, Iuliano L, Mauriello A, Spagnoli L, Lawson JA, Rokach J, Maclouf J, Violi F, and FitzGerald GA (1997) Localization of distinct F2-isoprostanes in human atherosclerotic lesions. J Clin Investig 100:2028-2034.
32. Rodriguez-Martinez MA, Garcia-Cohen EC, Baena AB, Gonzalez R, Salaices M, and Marin J (1998) Contractile responses elicited by hydrogen peroxide in aorta from normotensive and hypertensive rats. Endothelial modulation and mechanism involved. Br J Pharmacol 125:1329-1335.
33. Takahashi K, Nammour TM, Fukunaga M, Ebert J, Morrow JD, Roberts LJ, Hoover RL, and Badr KF (1992) Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2à, in the rat: evidence for interaction with thromboxane A2 receptors. J Clin Investig 90:136-141.
34. Thannickal VJ and Fanburg BL (2000) Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279:L1005-L1028.
35. Watkins MT, Patton GM, Soler HM, Albadawi H, Humphries DE, Evans JE, and Kadowaki H (1999) Synthesis of 8-epi-prostaglandin F2alpha by human endothelial cells: role of prostaglandin H2 synthase. Biochem J 344 (Pt 3):747-754.
36. Weintraub NL, Stephenson AH, Sprague RS, McMurdo L, and Lonigro AJ (1995) Relationship of arachidonic acid release to porcine coronary artery relaxation. Hypertension 26:684-690.
37. White R and Hiley CR (1997) A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. Br J Pharmacol 122: 1573-1584.
38. Yang ZH, von Segesser L, Bauer E, Stulz P, Turina M, and Luscher TF (1991) Different activation of the endothelial L-arginine and cyclooxygenase pathway in the human internal mammary artery and saphenous vein. Circ Res 68:52-60.
39. Zygmunt PM, Hogestatt ED, Waldeck K, Edwards G, Kirkup AJ, and Weston AH (1997) Studies on the effects of anandamide in rat hepatic artery. Br J Pharmacology 122:1679-1686.